Applied dna reports third quarter fiscal 2022 financial results

Stony brook, n.y.--(business wire)---- $apdn #lineardna--applied dna sciences, inc. (nasdaq: apdn) (“applied dna” or the “company”), a leader in pcr-based dna technologies, today announced consolidated financial results for the third quarter of fiscal 2022, ended june 30, 2022. the company's results are in line with preliminary selected quarterly results issued in the company's form s-1/a filed on august 1, 2022. “we executed well in the fiscal third quarter, managing our financial results through covid-19 testing
APDN Ratings Summary
APDN Quant Ranking